STING1 and ovarian carcinoma: Future functional experiments are needed to elucidate the role of STING in ovarian carcinomas and to assess the integrity of the cGAS-STING pathway, which will help to provide more appropriate therapeutic strategies for different ovarian cancer subtypes.